Neonatal hypoxia ischaemia: mechanisms, models, and therapeutic challenges

LJ Millar, L Shi, A Hoerder-Suabedissen… - Frontiers in cellular …, 2017 - frontiersin.org
Neonatal hypoxia-ischaemia (HI) is the most common cause of death and disability in
human neonates, and is often associated with persistent motor, sensory, and cognitive …

Fuel metabolism in starvation

GF Cahill Jr - Annu. Rev. Nutr., 2006 - annualreviews.org
▪ Abstract This article, which is partly biographical and partly scientific, summarizes a life in
academic medicine. It relates my progress from benchside to bedside and then to academic …

Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment

EP Yıldız, B Ekici, B Tatlı - Expert review of neurotherapeutics, 2017 - Taylor & Francis
Introduction: Hypoxic ischemic encephalopathy (HIE) is the most important reason for
morbidity and mortality in term-born infants. Understanding pathophysiology of the brain …

Brain-immune interactions in perinatal hypoxic-ischemic brain injury

B Li, K Concepcion, X Meng, L Zhang - Progress in neurobiology, 2017 - Elsevier
Perinatal hypoxia-ischemia remains the primary cause of acute neonatal brain injury,
leading to a high mortality rate and long-term neurological deficits, such as behavioral …

Role of prenatal hypoxia in brain development, cognitive functions, and neurodegeneration

NN Nalivaeva, AJ Turner, IA Zhuravin - Frontiers in neuroscience, 2018 - frontiersin.org
This review focuses on the role of prenatal hypoxia in the development of brain functions in
the postnatal period and subsequent increased risk of neurodegenerative disorders in later …

Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy

BJ Dixon, C Reis, WM Ho, J Tang… - International journal of …, 2015 - mdpi.com
Neonatal hypoxic ischemic encephalopathy (HIE) is a devastating disease that primarily
causes neuronal and white matter injury and is among the leading cause of death among …

Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection

J Puyal, V Ginet, PGH Clarke - Progress in neurobiology, 2013 - Elsevier
There is currently no approved neuroprotective pharmacotherapy for acute conditions such
as stroke and cerebral asphyxia. One of the reasons for this may be the multiplicity of cell …

Rodent hypoxia–ischemia models for cerebral palsy research: a systematic review

P Rumajogee, T Bregman, SP Miller, JY Yager… - Frontiers in …, 2016 - frontiersin.org
Cerebral palsy (CP) is a complex multifactorial disorder, affecting approximately 2.5–3/1000
live term births, and up to 22/1000 prematurely born babies. CP results from injury to the …

Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance

RA Stetler, RK Leak, Y Gan, P Li, F Zhang, X Hu… - Progress in …, 2014 - Elsevier
Preconditioning is a phenomenon in which brief episodes of a sublethal insult induce robust
protection against subsequent lethal injuries. Preconditioning has been observed in multiple …

Astrocytes in cerebral ischemic injury: morphological and general considerations

KS Panickar, MD Norenberg - Glia, 2005 - Wiley Online Library
Asrocytic responses constitute one of the earliest and most prominent changes in the CNS
following ischemic injury. Astrocytes are known to carry out critical functions such as …